228 related articles for article (PubMed ID: 29150476)
21. The predictive value of M30 and oxidative stress for left ventricular remodeling in patients with anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Türkoğlu C; Gür M; Şeker T; Selek Ş; Koçyiğit A
Coron Artery Dis; 2016 Dec; 27(8):690-695. PubMed ID: 27479531
[TBL] [Abstract][Full Text] [Related]
22. Presence of post-systolic shortening is an independent predictor of heart failure in patients following ST-segment elevation myocardial infarction.
Brainin P; Haahr-Pedersen S; Sengeløv M; Olsen FJ; Fritz-Hansen T; Jensen JS; Biering-Sørensen T
Int J Cardiovasc Imaging; 2018 May; 34(5):751-760. PubMed ID: 29230597
[TBL] [Abstract][Full Text] [Related]
23. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
[TBL] [Abstract][Full Text] [Related]
24. Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.
Leibundgut G; Gick M; Morel O; Ferenc M; Werner KD; Comberg T; Kienzle RP; Buettner HJ; Neumann FJ
Clin Res Cardiol; 2016 May; 105(5):432-40. PubMed ID: 26563201
[TBL] [Abstract][Full Text] [Related]
25. Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
Jia S; Zhao Y; Yang J; Zhao X; Xu H; Gao R; Wang Q; Li J; Yuan J; Yang Y
Catheter Cardiovasc Interv; 2019 Feb; 93(S1):793-799. PubMed ID: 30637931
[TBL] [Abstract][Full Text] [Related]
26. Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
Farag M; Spinthakis N; Gue YX; Srinivasan M; Sullivan K; Wellsted D; Gorog DA
Eur Heart J; 2019 Jan; 40(3):295-305. PubMed ID: 30380032
[TBL] [Abstract][Full Text] [Related]
27. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.
Kosmidou I; McAndrew T; Redfors B; Embacher M; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724652
[TBL] [Abstract][Full Text] [Related]
28. The value of D-dimer to lymphocyte ratio in predicting clinical outcomes after percutaneous coronary intervention in ST-segment elevation myocardial infarction patients: A retrospective study.
Cao S; Liu Y; Ye J; Wang Y; Wang Z; Li C; Jin T; Wu J; Zong G
Int Immunopharmacol; 2024 Feb; 128():111556. PubMed ID: 38241843
[TBL] [Abstract][Full Text] [Related]
29. Triglyceride to high density lipoprotein cholesterol ratio may serve as a useful predictor of major adverse coronary event in female revascularized ST-elevation myocardial infarction.
Wan GX; Xia WB; Ji LH; Qin HL; Zhang YG
Clin Chim Acta; 2018 Oct; 485():166-172. PubMed ID: 29969621
[TBL] [Abstract][Full Text] [Related]
30. Serial measurements of neutrophil gelatinase-associated lipocalin: prognostic value in patients with ST-segment elevation myocardial infarction treated with a primary percutaneous coronary intervention.
Lim YM; Moon JY; Min D; Kim SH; Yang WI; Kim WJ; Sung JH; Kim IJ; Lim SW; Cha DH
Coron Artery Dis; 2017 Dec; 28(8):690-696. PubMed ID: 28737526
[TBL] [Abstract][Full Text] [Related]
31. Association between apelin-12 and creatine kinase-MB, depending on success of reperfusion in STEMI patients.
Krasniqi X; Vincelj J; Gashi M; Berisha B; Kocinaj D
Cardiovasc J Afr; 2024 Jan-Apr 23; 35(1):35-39. PubMed ID: 37171284
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
33. Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction.
Zhang E; Li Z; Che J; Chen X; Qin T; Tong Q; Zhao W; Li G
Am J Med Sci; 2015 Jun; 349(6):493-8. PubMed ID: 25978119
[TBL] [Abstract][Full Text] [Related]
34. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
[TBL] [Abstract][Full Text] [Related]
35. Combination of eosinophil percentage and high-sensitivity C-reactive protein predicts in-hospital major adverse cardiac events in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Ye L; Bai HM; Jiang D; He B; Wen XS; Ge P; Zhang DY
J Clin Lab Anal; 2020 Sep; 34(9):e23367. PubMed ID: 32441412
[TBL] [Abstract][Full Text] [Related]
36. Circulating Long Noncoding RNA LIPCAR Acts as a Novel Biomarker in Patients with ST-Segment Elevation Myocardial Infarction.
Li M; Wang YF; Yang XC; Xu L; Li WM; Xia K; Zhang DP; Wu RN; Gan T
Med Sci Monit; 2018 Jul; 24():5064-5070. PubMed ID: 30030914
[TBL] [Abstract][Full Text] [Related]
37. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction.
Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I
Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849
[TBL] [Abstract][Full Text] [Related]
39. Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction.
Mitsuda T; Uemura Y; Ishii H; Takemoto K; Uchikawa T; Koyasu M; Ishikawa S; Miura A; Imai R; Iwamiya S; Ozaki Y; Kato T; Shibata R; Watarai M; Murohara T
Heart Vessels; 2016 Dec; 31(12):1923-1929. PubMed ID: 26936452
[TBL] [Abstract][Full Text] [Related]
40. Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.
Wang YP; Wang JH; Wang XL; Liu JY; Jiang FY; Huang XL; Hang JY; Qin W; Ma SX; Zhang J; Yuan MJ; Li JB; Lu ZG; Wei M
J Cell Mol Med; 2017 Nov; 21(11):2677-2684. PubMed ID: 28623858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
